Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
-1.77%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$54B
AUM Growth
-$3.22B
(-5.6%)
Cap. Flow
-$953M
Cap. Flow
% of AUM
-1.77%
Top 10 Holdings %
Top 10 Hldgs %
28.72%
Holding
985
New
115
Increased
314
Reduced
359
Closed
149
Top Buys
| 1 |
Hubbell
HUBB
|
$208M |
| 2 |
Norfolk Southern
NSC
|
$145M |
| 3 |
Insmed
INSM
|
$137M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$136M |
| 5 |
Soleno Therapeutics
SLNO
|
$116M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$355M |
| 2 |
Royalty Pharma
RPRX
|
$334M |
| 3 |
McDonald's
MCD
|
$198M |
| 4 |
Union Pacific
UNP
|
$188M |
| 5 |
HES
Hess
HES
|
$182M |
Sector Composition
| 1 | Technology | 26.31% |
| 2 | Healthcare | 15% |
| 3 | Financials | 12.57% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
KKR & Co
KKR
$121B
| $71.3M | 0.13% |
616,600
-13,100
| -2% | -$1.51M |
|
152
Amgen
AMGN
$153B
| $70.4M | 0.13% |
225,868
-78,859
| -26% | -$24.6M |
|
153
United Parcel Service
UPS
$72.1B
| $70M | 0.13% |
636,500
-37,300
| -6% | -$4.1M |
|
154
American Tower
AMT
$92.9B
| $69.9M | 0.13% |
321,105
+124,500
| +63% | +$27.1M |
|
155
Analog Devices
ADI
$122B
| $69.4M | 0.13% |
344,214
-65,023
| -16% | -$13.1M |
|
156
KLA
KLAC
$119B
| $69.1M | 0.13% |
101,654
-3,200
| -3% | -$2.18M |
|
157
Axalta
AXTA
$6.89B
| $68.8M | 0.13% |
2,075,000
+305,000
| +17% | +$10.1M |
|
158
CrowdStrike
CRWD
$105B
| $68.8M | 0.13% |
195,100
-1,300
| -0.7% | -$458K |
|
159
Colgate-Palmolive
CL
$68.8B
| $68.4M | 0.13% |
729,670
-213,200
| -23% | -$20M |
|
160
Aon
AON
$79.9B
| $68.2M | 0.13% |
170,969
+78,900
| +86% | +$31.5M |
|
161
Exelon
EXC
$43.9B
| $67.6M | 0.13% |
1,467,432
+528,600
| +56% | +$24.4M |
|
162
Monolithic Power Systems
MPWR
$41.5B
| $67.3M | 0.12% |
116,100
+22,500
| +24% | +$13M |
|
163
Gulfport Energy Corp
GPOR
$3.08B
| $67M | 0.12% |
363,850
+43,450
| +14% | +$8M |
|
164
Motorola Solutions
MSI
$79.8B
| $66.7M | 0.12% |
152,364
-58,800
| -28% | -$25.7M |
|
165
Praxis Precision Medicines
PRAX
$986M
| $66M | 0.12% |
1,742,758
+1,137,748
| +188% | +$43.1M |
|
166
Ovintiv
OVV
$10.6B
| $65.7M | 0.12% |
1,534,004
+790,000
| +106% | +$33.8M |
|
167
Arista Networks
ANET
$180B
| $65.3M | 0.12% |
842,800
-73,000
| -8% | -$5.66M |
|
168
Insulet
PODD
$24.5B
| $65M | 0.12% |
247,636
+92,136
| +59% | +$24.2M |
|
169
GE Vernova
GEV
$158B
| $64.9M | 0.12% |
212,673
+67,264
| +46% | +$20.5M |
|
170
Scholar Rock
SRRK
$3.02B
| $64.9M | 0.12% |
2,018,000
+423,131
| +27% | +$13.6M |
|
171
Xenon Pharmaceuticals
XENE
$3.02B
| $64.2M | 0.12% |
1,914,749
+51,276
| +3% | +$1.72M |
|
172
Hanover Insurance
THG
$6.35B
| $63.5M | 0.12% |
365,000
+76,100
| +26% | +$13.2M |
|
173
Madrigal Pharmaceuticals
MDGL
$9.65B
| $63.5M | 0.12% |
191,609
+171,649
| +860% | +$56.9M |
|
174
Shell
SHEL
$208B
| $63.4M | 0.12% |
865,000
+65,000
| +8% | +$4.76M |
|
175
Avidity Biosciences
RNA
$6.48B
| $63.3M | 0.12% |
2,145,881
-606,063
| -22% | -$17.9M |
|